Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease

Soluble Epoxide Hydrolase Deficiency Attenuates Neointima Formation in the Femoral Cuff Model of Hyperlipidemic Mice

(2010) Marc Revermann et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pharmacological inhibition of the soluble epoxide hydrolase—from mouse to man

(2010) Marc Revermann   CURRENT OPINION IN PHARMACOLOGY

Lipoxins: regulators of resolution

(2010) Aidan Ryan et al.   CURRENT OPINION IN PHARMACOLOGY

Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection

(2009) Alexis N. Simpkins et al.   AMERICAN JOURNAL OF PATHOLOGY

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

(2009) Jun-Yan Liu et al.   BIOCHEMICAL PHARMACOLOGY

Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats

(2009) Marc Revermann et al.   JOURNAL OF HYPERTENSION

Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase

(2008) Alan R. Parrish et al.   CELL BIOLOGY AND TOXICOLOGY

Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto–Kakizaki rats

(2008) Jeffrey J. Olearczyk et al.   CLINICAL SCIENCE

Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response

(2008) Benjamin Keserü et al.   FASEB JOURNAL

Genetic Variations in Soluble Epoxide Hydrolase and Graft Function in Kidney Transplantation

(2008) S.H. Lee et al.   TRANSPLANTATION PROCEEDINGS

Vascular Cytochrome P450 Enzymes: Physiology and Pathophysiology

(2008) Ingrid Fleming   TRENDS IN CARDIOVASCULAR MEDICINE